We are live on
!
Find out more
CWM
CIBC World Markets Portfolio holdings
AUM
$20.8B
This Fund
S&P 500
This Quarter
Est. Return
-3.31%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$12.7B
AUM Growth
-$4.36B
(-26%)
Cap. Flow
-$3.8B
Cap. Flow
% of AUM
-29.89%
Top 10 Holdings %
Top 10 Hldgs %
38.21%
Holding
1,893
New
568
Increased
757
Reduced
513
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$211M |
| 2 |
Crown Castle
CCI
|
+$52.2M |
| 3 |
Tesla
TSLA
|
+$46.6M |
| 4 |
XP
XP
|
+$25.2M |
| 5 |
EA
Electronic Arts
EA
|
+$22.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$587M |
| 2 |
Honeywell
HON
|
+$142M |
| 3 |
Mastercard
MA
|
+$126M |
| 4 |
Apple
AAPL
|
+$111M |
| 5 |
Meta Platforms (Facebook)
META
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.12% |
| 2 | Financials | 11.86% |
| 3 | Consumer Discretionary | 10.19% |
| 4 | Communication Services | 9.97% |
| 5 | Healthcare | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVRI
1351
DELISTED
Everi Holdings
EVRI
| $246K | ﹤0.01% |
+18,001
| New | +$246K |
|
1352
Dime Commercial Bancshares
DCOM
$1.78B
| $246K | ﹤0.01% |
+8,818
| New | +$267K |
|
1353
Diebold Nixdorf
DBD
$2.56B
| $245K | ﹤0.01% |
+5,609
| New | +$244K |
|
1354
Wolverine World Wide
WWW
$1.55B
| $245K | ﹤0.01% |
+17,616
| New | +$322K |
|
1355
AdaptHealth
AHCO
$759M
| $245K | ﹤0.01% |
+22,589
| New | +$227K |
|
|
NVEE
1356
DELISTED
NV5 Global
NVEE
| $244K | ﹤0.01% |
+12,674
| New | +$232K |
|
1357
Sprout Social
SPT
$621M
| $244K | ﹤0.01% |
+11,103
| New | +$323K |
|
1358
1st Source
SRCE
$2.12B
| $244K | ﹤0.01% |
+4,073
| New | +$251K |
|
1359
Schrodinger
SDGR
$1.36B
| $244K | ﹤0.01% |
+12,338
| New | +$278K |
|
1360
Amphastar Pharmaceuticals
AMPH
$916M
| $243K | ﹤0.01% |
+8,399
| New | +$268K |
|
|
DX
1361
Dynex Capital
DX
$3.21B
| $243K | ﹤0.01% |
+18,669
| New | +$250K |
|
1362
Evolent Health
EVH
$447M
| $243K | ﹤0.01% |
25,616
+14,813
| +137% | +$150K |
|
1363
Xometry
XMTR
$5.34B
| $242K | ﹤0.01% |
+9,729
| New | +$306K |
|
|
VRNT
1364
DELISTED
Verint Systems
VRNT
| $242K | ﹤0.01% |
+13,559
| New | +$324K |
|
1365
Vera Therapeutics
VERA
$2.36B
| $242K | ﹤0.01% |
+10,056
| New | +$323K |
|
1366
LegalZoom.com
LZ
$988M
| $241K | ﹤0.01% |
27,986
+15,992
| +133% | +$143K |
|
1367
PROG Holdings
PRG
$1.71B
| $241K | ﹤0.01% |
+9,051
| New | +$320K |
|
1368
Dole
DOLE
$1.32B
| $241K | ﹤0.01% |
+16,654
| New | +$230K |
|
1369
US Physical Therapy
USPH
$1.22B
| $240K | ﹤0.01% |
+3,320
| New | +$279K |
|
1370
Aurinia Pharmaceuticals
AUPH
$2.11B
| $240K | ﹤0.01% |
29,789
+17,226
| +137% | +$140K |
|
1371
Adient
ADNT
$1.5B
| $239K | ﹤0.01% |
+18,559
| New | +$298K |
|
1372
Sabre
SABR
$835M
| $238K | ﹤0.01% |
84,831
+49,052
| +137% | +$174K |
|
|
CSR
1373
Centerspace
CSR
$952M
| $238K | ﹤0.01% |
+3,673
| New | +$232K |
|
1374
SFL Corp
SFL
$1.61B
| $238K | ﹤0.01% |
28,983
+16,760
| +137% | +$162K |
|
1375
German American Bancorp
GABC
$1.9B
| $237K | ﹤0.01% |
+6,324
| New | +$249K |
|
Similar funds
VRS
FAF
BGIM
CIM
PPFA
UOC
FNBT
CIBC World Markets's Q1 2025 Portfolio in Review
As of Q1 2025, CIBC World Markets held 1,893 positions worth $12.7B, down 26% from $17.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
CIBC World Markets withdrew a net $3.8B in Q1 2025, closing 51 positions and reducing 513 holdings. Its most notable exit was Apellis Pharmaceuticals, an estimated $41M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, CIBC World Markets opened a new position in XP worth $25.2M.
- CIBC World Markets's largest Q1 2025 buy was XP: 1,832,600 shares worth $25.2M.
- CIBC World Markets added most to Microsoft in Q1 2025, an estimated $211M increase.
- CIBC World Markets's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $587M.
- CIBC World Markets fully exited Apellis Pharmaceuticals in Q1 2025, selling an estimated $41M.
- CIBC World Markets's ten largest holdings make up 38% of its $12.7B portfolio in Q1 2025.
- CIBC World Markets opened 568 new positions and closed 51 in Q1 2025.
- CIBC World Markets's portfolio value fell 26% quarter-over-quarter to $12.7B.
Based on CIBC World Markets's 13F filing for Q1 2025, filed 13 May 2025.